136 related articles for article (PubMed ID: 36100144)
21. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
Kim SH; Kim GR; Jeong J; Kim S; Shin JH
Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
[TBL] [Abstract][Full Text] [Related]
22. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients.
Castón JJ; Lacort-Peralta I; Martín-Dávila P; Loeches B; Tabares S; Temkin L; Torre-Cisneros J; Paño-Pardo JR
Int J Infect Dis; 2017 Jun; 59():118-123. PubMed ID: 28392315
[TBL] [Abstract][Full Text] [Related]
24. Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.
Iacchini S; Sabbatucci M; Gagliotti C; Rossolini GM; Moro ML; Iannazzo S; D'Ancona F; Pezzotti P; Pantosti A
Euro Surveill; 2019 Jan; 24(5):. PubMed ID: 30722813
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and management of Enterobacteriaceae harboring IMP-4 or IMP-8 carbapenemase in a tertiary hospital.
Pang F; Jia XQ; Song ZZ; Li YH; Wang B; Zhao QG; Wang CX; Zhang Y; Wang LX
Afr Health Sci; 2016 Mar; 16(1):153-61. PubMed ID: 27358627
[TBL] [Abstract][Full Text] [Related]
26. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
[TBL] [Abstract][Full Text] [Related]
28. Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp.
Song W; Hong SG; Yong D; Jeong SH; Kim HS; Kim HS; Kim JS; Bae IK
Ann Lab Med; 2015 Mar; 35(2):212-9. PubMed ID: 25729723
[TBL] [Abstract][Full Text] [Related]
29. Three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection in Japan.
Hamada Y; Watanabe K; Tada T; Mezaki K; Takeuchi S; Shimizu T; Kirikae T; Ohmagari N
J Infect Chemother; 2013 Oct; 19(5):956-8. PubMed ID: 23160627
[TBL] [Abstract][Full Text] [Related]
30. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
31. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.
Gutiérrez-Gutiérrez B; Salamanca E; de Cueto M; Hsueh PR; Viale P; Paño-Pardo JR; Venditti M; Tumbarello M; Daikos G; Cantón R; Doi Y; Tuon FF; Karaiskos I; Pérez-Nadales E; Schwaber MJ; Azap ÖK; Souli M; Roilides E; Pournaras S; Akova M; Pérez F; Bermejo J; Oliver A; Almela M; Lowman W; Almirante B; Bonomo RA; Carmeli Y; Paterson DL; Pascual A; Rodríguez-Baño J;
Lancet Infect Dis; 2017 Jul; 17(7):726-734. PubMed ID: 28442293
[TBL] [Abstract][Full Text] [Related]
32. Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.
Caméléna F; Cointe A; Mathy V; Hobson C; Doit C; Bercot B; Decré D; Podglajen I; Dortet L; Monjault A; Bidet P; Bonacorsi S; Birgy A
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29950336
[TBL] [Abstract][Full Text] [Related]
33. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
Albiger B; Glasner C; Struelens MJ; Grundmann H; Monnet DL;
Euro Surveill; 2015; 20(45):. PubMed ID: 26675038
[TBL] [Abstract][Full Text] [Related]
34. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
[TBL] [Abstract][Full Text] [Related]
35. The Magnitude of Carbapenemase and ESBL Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections at Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia.
Seman A; Sebre S; Awoke T; Yeshitela B; Asseffa A; Asrat D; Abebe T; Mihret A
Adv Exp Med Biol; 2022; 1369():117-128. PubMed ID: 34914083
[TBL] [Abstract][Full Text] [Related]
36. Performance of a Novel Fluorogenic Assay for Detection of Carbapenemase-Producing
Kim HS; Kim JO; Lee JE; Park KG; Lee HK; Kim SY; Min SJ; Kim J; Park YJ
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666362
[TBL] [Abstract][Full Text] [Related]
37. Bacteremia with Carbapenemase-Producing
Averbuch D; Moshkovitz L; Ilan S; Abu Ahmad W; Temper V; Strahilevitz J
Microb Drug Resist; 2022 May; 28(5):593-600. PubMed ID: 35580283
[TBL] [Abstract][Full Text] [Related]
38. Intra-Abdominal Infections by Carbapenemase-Producing
Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
Surg Infect (Larchmt); 2021 Apr; 22(3):266-273. PubMed ID: 32598237
[No Abstract] [Full Text] [Related]
39. Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
Huang YT; Kuo YW; Lee NY; Tien N; Liao CH; Teng LJ; Ko WC; Hsueh PR;
Microbiol Spectr; 2022 Feb; 10(1):e0172821. PubMed ID: 35019772
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam.
De la Calle C; Rodríguez O; Morata L; Marco F; Cardozo C; García-Vidal C; Río AD; Feher C; Pellicé M; Puerta-Alcalde P; Mensa J; Soriano A; Martínez JA
Int J Antimicrob Agents; 2019 Apr; 53(4):520-524. PubMed ID: 30471403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
